Does GLATIRAMER Cause Mobility decreased? 254 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 254 reports of Mobility decreased have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.6% of all adverse event reports for GLATIRAMER.
254
Reports of Mobility decreased with GLATIRAMER
0.6%
of all GLATIRAMER reports
0
Deaths
46
Hospitalizations
How Dangerous Is Mobility decreased From GLATIRAMER?
Of the 254 reports, 46 (18.1%) required hospitalization, and 2 (0.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 254 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which GLATIRAMER Alternatives Have Lower Mobility decreased Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE